Evidence map›Paper›PMID 32441445›Full record

ArticleJournal of leukocyte biology2021

Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection.

Kai J Rogers, Olena Shtanko, Laura L Stunz, Laura N Mallinger, Tina Arkee, Megan E Schmidt, Dana Bohan, Bethany Brunton, Judith M White, Steve M Varga and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Compound FC-10696 Inhibits Egress of Marburg Virus.Antimicrobial agents and chemotherapy · 2021
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Kai J RogersDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
Olena ShtankoHost-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Laura L StunzDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
Laura N MallingerDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
Tina ArkeeInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, USA.
Megan E SchmidtInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, USA.
Dana BohanInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa, USA.
Bethany BruntonDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.
Judith M WhiteDepartment of Cell Biology, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-0532-996X
Steve M VargaDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0001-7332-4290
Noah S ButlerDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0002-1429-0796
Gail A BishopDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0002-1291-5078
Wendy MauryDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.ORCID 0000-0002-9892-4484
University of Iowa · USTexas Biomedical Research Institute · USUniversity of Virginia · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
TRAINING IN MECHANISMS OF PARASITISMT32AI007511 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WEBER, MARY · 1996 to 2025
$8.1M
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Regulation of Plasmodium-specific CD4+ T CellsR01AI127481 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.8M
Development and function of CD4+ memory T cells during malariaR01AI125446 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Noah Sullivan Butler · 2016 to 2026
$3.7M
Predoctoral Training in the Pharmacological SciencesT32GM067795 · NIGMS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2004 to 2021
$3.4M
Modeling Filovirus Infection of and Trafficking through SkinR01AI134733 · NIAID · UNIVERSITY OF IOWA · PI MAURY, WENDY JEAN · 2018 to 2021
$3.1M
Predoctoral Training in the Pharmacological SciencesT32GM144636 · NIGMS · UNIVERSITY OF IOWA · PI David L. Roman, STEFAN STRACK · 2022 to 2026
$1.9M
Balancing protection versus immunopathology by RSV-specific memory CD8 T cellsR01AI124093 · NIAID · UNIVERSITY OF IOWA · PI VARGA, STEVEN M · 2017 to 2020
$1.6M
Combinations of Approved Drugs to Combat Ebola VirusR01AI114776 · NIAID · UNIVERSITY OF VIRGINIA · PI WHITE, JUDITH M. · 2015 to 2017
$1.5M
BLRD VA I01 BX001702NCI NIH HHS P30 CA086862NIAID NIH HHS R01 AI114776NIAID NIH HHS R01 AI124093NIAID NIH HHS R01 AI125446NIAID NIH HHS R01 AI127481NIAID NIH HHS R01 AI134733NIAID NIH HHS R21 AI119163NIAID NIH HHS R21 AI139902NIAID NIH HHS R21 AI144215NIAID NIH HHS T32 AI007511NIEHS NIH HHS P30 ES005605NIGMS NIH HHS T32 GM007337NIGMS NIH HHS T32 GM067795NIGMS NIH HHS T32 GM144636NIH HHS AI114776NIH HHS AI119163NIH HHS I01 BX001702NIH HHS R01AI125446NIH HHS R01AI127481NIH HHS R21 AI139902NIH HHS R21 AI144215NIH HHS RO1AI124093NIH HHS T32GM007337University of Iowa Department of Microbiology and Immunology Developmental Grant
6 · The paper itself

Abstract

Many acute viral infections target tissue Mϕs, yet the mechanisms of Mϕ-mediated control of viruses are poorly understood. Here, we report that CD40 expressed by peritoneal Mϕs restricts early infection of a broad range of RNA viruses. Loss of CD40 expression enhanced virus replication as early as 12-24 h of infection and, conversely, stimulation of CD40 signaling with an agonistic Ab blocked infection. With peritoneal cell populations infected with the filovirus, wild-type (WT) Ebola virus (EBOV), or a BSL2 model virus, recombinant vesicular stomatitis virus encoding Ebola virus glycoprotein (rVSV/EBOV GP), we examined the mechanism conferring protection. Here, we demonstrate that restricted virus replication in Mϕs required CD154/CD40 interactions that stimulated IL-12 production through TRAF6-dependent signaling. In turn, IL-12 production resulted in IFN-γ production, which induced proinflammatory polarization of Mϕs, protecting the cells from infection. These CD40-dependent events protected mice against virus challenge. CD40

Indexed as

Immunity, InnateSignal TransductionAcute DiseaseAnimalsCD40 AntigensCD40 LigandEbolavirusGlycoproteinsHumansInterferon-gammaInterleukin-12MacrophagesMiceMice, Inbred C57BLModels, BiologicalPeritoneumCD40 AntigensCD40 LigandGlycoproteinsInterferon-gammaInterleukin-12TNF Receptor-Associated Factor 6CD40CD40 signalingEbola virusfilovirusIFN-γIL-12innate immunityMϕperitoneumRNA virusTRAF6virus restriction

Identifiers

PMID32441445
PMCPMC7774454
OpenAlexW3026127770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.